{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:34:40Z","timestamp":1742639680236,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T00:00:00Z","timestamp":1516752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001594","name":"Irish Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001594","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Service Executive"},{"name":"National Lottery"},{"DOI":"10.13039\/100015471","name":"Mater Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015471","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s11845-018-1739-8","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T14:10:13Z","timestamp":1516803013000},"page":"739-746","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Suboptimal lipid management before and after ischaemic stroke and TIA\u2014the North Dublin Population Stroke Study"],"prefix":"10.1007","volume":"187","author":[{"given":"Danielle","family":"N\u00ed Chr\u00f3in\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantelle","family":"N\u00ed Chr\u00f3in\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layan","family":"Akijian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth L.","family":"Callaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Hannon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Marnane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ine","family":"Merwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3rla","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Kyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eamon","family":"Dolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se\u00e1n","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,24]]},"reference":[{"key":"1739_CR1","unstructured":"World Health Organization (2009) Global health risks: mortality and burden of disease attributable to selected major risks. \n                    http:\/\/www.who.int\/healthinfo\/global_burden_disease\/GlobalHealthRisks_report_full.pdf\n                    \n                   Accessed 8 August 2017"},{"key":"1739_CR2","unstructured":"Hockley T, Gemmill M (2007) European Cholesterol Guidelines report. \n                    https:\/\/policy-centrecom\/wp-content\/uploads\/2017\/04\/European-Cholesterol-Guidelines07pdf\n                    \n                   Accessed 8 August 2017"},{"key":"1739_CR3","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","year":"2011","unstructured":"Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) (2011) ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J 32:1769\u20131818","journal-title":"Eur Heart J"},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","unstructured":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third report. Circulation 106:3143\u20133421","journal-title":"Circulation"},{"issue":"2","key":"1739_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","volume":"110","author":"SM Grundy","year":"2004","unstructured":"Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ, National Heart, Lung, and Blood Institute, American College of Cardiology Foundation., American Heart Association (2004) Implications of recent clinical trials for the National Choelesterol Education Program Adult Treatment Panel III guidelines. Circulation 110(2):227\u2013239. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000133317.49796.0E","journal-title":"Circulation"},{"issue":"25 Suppl 2","key":"1739_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","volume":"129","author":"NJ Stone","year":"2014","unstructured":"Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (2014) 2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 129(25 Suppl 2):S1\u2013S45. \n                    https:\/\/doi.org\/10.1161\/01.cir.0000437738.63853.7a","journal-title":"Circulation"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1001\/archinte.164.2.203","volume":"164","author":"KA LaBresh","year":"2003","unstructured":"LaBresh KA, Ellrodt AG, Glijklich R et al (2003) Get with the guidelines for cardiovascular secondary prevention: pilot results. Arch Intern Med 164:203\u2013209","journal-title":"Arch Intern Med"},{"issue":"4","key":"1739_CR8","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/jhm.102","volume":"1","author":"B Ovbiagele","year":"2006","unstructured":"Ovbiagele B, Hills NK, Saver JL, Johnston SC, For the CASPR Investigators (2006) Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients. J Hosp Med 1(4):214\u2013220. \n                    https:\/\/doi.org\/10.1002\/jhm.102","journal-title":"J Hosp Med"},{"issue":"1","key":"1739_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.STR.0000195127.12990.43","volume":"37","author":"AJ Mullard","year":"2006","unstructured":"Mullard AJ, Reeves MJ, Jacobs BS, Kothari RU, Birbeck GL, Maddox K, Stoeckle-Roberts S, Wehner S, Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators (2006) Lipid testing and lipid-lowering therapy in hospitalized ischemic stroke and transient ischemic attack patients. Results from a statewide registry. Stroke 37(1):44\u201349. \n                    https:\/\/doi.org\/10.1161\/01.STR.0000195127.12990.43","journal-title":"Stroke"},{"issue":"9","key":"1739_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/01.wnl.0000255941.03761.dc","volume":"68","author":"EE Smith","year":"2007","unstructured":"Smith EE, Abdullah AR, Amirfarzan H, Schwamm LH (2007) Serum lipid profile on admission for ischemic stroke. Neurology 68(9):660\u2013665. \n                    https:\/\/doi.org\/10.1212\/01.wnl.0000255941.03761.dc","journal-title":"Neurology"},{"key":"1739_CR11","doi-asserted-by":"publisher","unstructured":"Hsieh FI, Lien LM, Chen ST et al Taiwan Stroke Registry Investigators. (2010) Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan. Circulation 122: 1116\u20131123, 11, DOI: \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.936526","DOI":"10.1161\/CIRCULATIONAHA.110.936526"},{"issue":"1","key":"1739_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000339578","volume":"2","author":"FA Carvalho De","year":"2012","unstructured":"De Carvalho FA, Schwamm LH, Kuster GW et al (2012) Get With The Guidelines Stroke performance indicators in a Brazilian tertiary hospital. Cerebrovasc Dis Extra 2(1):26\u201335. \n                    https:\/\/doi.org\/10.1159\/000339578","journal-title":"Cerebrovasc Dis Extra"},{"key":"1739_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2377-14-53","volume":"14","author":"I Cavanero","year":"2014","unstructured":"Cavanero I, Cavallini A, Perrone P et al (2014) Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry. BMC Neurol 14:53","journal-title":"BMC Neurol"},{"issue":"8","key":"1739_CR14","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1161\/STROKEAHA.111.645721","volume":"43","author":"PJ Kelly","year":"2012","unstructured":"Kelly PJ, Crispino G, Sheehan O, Kelly L, Marnane M, Merwick A, Hannon N, Ni Chroinin D, Callaly E, Harris D, Horgan G, Williams EB, Duggan J, Kyne L, McCormack P, Dolan E, Williams D, Moroney J, Kelleher C, Daly L (2012) Incidence, event rates, and early outcome of stroke in Dublin, Ireland. The North Dublin Population Stroke Study. Stroke 43(8):2042\u20132047. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.111.645721","journal-title":"Stroke"},{"key":"1739_CR15","volume-title":"Volumes 1, 2","author":"Central Statistics Office Ireland (2007) Census of population of Ireland","year":"2006","unstructured":"Central Statistics Office Ireland (2007) Census of population of Ireland (2006) Volumes 1, 2. Stationary Office, Dublin"},{"issue":"3","key":"1739_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/01.STR.20.3.333","volume":"20","author":"MS Dennis","year":"1989","unstructured":"Dennis MS, Bamford JM, Sandercock PAG et al (1989) Incidence of transient ischaemic attacks in Oxfordshire, England. Stroke 20(3):333\u2013339. \n                    https:\/\/doi.org\/10.1161\/01.STR.20.3.333","journal-title":"Stroke"},{"issue":"10","key":"1739_CR17","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1161\/STROKEAHA.107.490292","volume":"38","author":"TS Olsen","year":"2007","unstructured":"Olsen TS, Christensen RH, Kammersgaard LP et al (2007) Higher total serum cholesterol levels are associated with less severe strokes and lower all-cause mortality: ten year follow-up of ischemic strokes in the Copenhagen Stroke Study. Stroke 38(10):2646\u20132651. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.107.490292","journal-title":"Stroke"},{"key":"1739_CR18","doi-asserted-by":"publisher","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation (18):1837\u20131847. \n                    https:\/\/doi.org\/10.1161\/01.CIR.97.18.1837","DOI":"10.1161\/01.CIR.97.18.1837"},{"issue":"2","key":"1739_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/STROKEAHA.112.668277","volume":"44","author":"D N\u00ed Chr\u00f3in\u00edn","year":"2013","unstructured":"N\u00ed Chr\u00f3in\u00edn D, Asplund K, \u00c5sberg S et al (2013) Statin therapy and outcome after ischemic stroke systematic review and meta-analysis of observational studies and randomized trials. Stroke 44(2):448\u2013456. \n                    https:\/\/doi.org\/10.1161\/STROKEAHA.112.668277","journal-title":"Stroke"},{"key":"1739_CR20","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/STROKEAHA.109.567693","volume":"41","author":"E Smith","year":"2010","unstructured":"Smith E, Pan W, Olson D et al (2010) Frequency and determinants of lipid testing in ischemic stroke and transient ischemic attack: findings from Get With The Guidelines-Stroke. Stroke 41:232\u2013238","journal-title":"Stroke"},{"issue":"2-3","key":"1739_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1159\/000093237","volume":"22","author":"P Amarenco","year":"2006","unstructured":"Amarenco P, Labreuche J, Elbaz A, Touboul PJ, Driss F, Jaillard A, Bruckert E, GENIC Investigators (2006) Blood lipids in brain infarction subtypes. Cerebrovasc Dis 22(2-3):101\u2013108. \n                    https:\/\/doi.org\/10.1159\/000093237","journal-title":"Cerebrovasc Dis"},{"issue":"11","key":"1739_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1212\/WNL.0b013e3182608c82","volume":"79","author":"K Nardi","year":"2012","unstructured":"Nardi K, Engelter S, Strbian D, Sarikaya H, Arnold M, Casoni F, Ford GA, Cordonnier C, Lyrer P, Bordet R, Soinne L, Gensicke H, Duriez P, Baumgartner RW, Tatlisumak T, Leys D, On behalf of the Lipid Profile in Thrombolysis Study Group (2012) Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia. Neurology 79(11):1101\u20131108. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e3182608c82","journal-title":"Neurology"},{"issue":"1","key":"1739_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000108156","volume":"7","author":"RJ Butterworth","year":"1997","unstructured":"Butterworth RJ, Marshall WJ, Bath PMW (1997) Changes in serum lipid measurements following acute ischaemic stroke. Cerebrovasc Dis 7(1):10\u201313. \n                    https:\/\/doi.org\/10.1159\/000108156","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"1739_CR24","doi-asserted-by":"publisher","first-page":"e008017","DOI":"10.1136\/bmjopen-2015-008017","volume":"5","author":"C Murphy","year":"2015","unstructured":"Murphy C, Bennett K, Fahey T et al (2015) Statin use in adults at high risk of cardiovascular disease mortality: cross-sectional analysis of baseline data from The Irish Longitudinal Study on Ageing (TILDA). BMJ Open 5(7):e008017. \n                    https:\/\/doi.org\/10.1136\/bmjopen-2015-008017","journal-title":"BMJ Open"},{"key":"1739_CR25","unstructured":"McElwaine P, McCormack J, Harbison J, on behalf of the National Stroke Programme Audit Steering Group, Irish Heart Foundation\/HSE National Stroke Audit 2015. December, 2015 \n                    http:\/\/wwwhseie\/eng\/services\/publications\/Clinical-Strategy-and-Programmes\/National-Stroke-Audit-2015pdf\n                    \n                  \/ Accessed 27 December 2017"},{"issue":"11 Suppl 1","key":"1739_CR26","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.2146\/ajhp150094","volume":"72","author":"KG Elder","year":"2015","unstructured":"Elder KG, Lemon SK, Costello TJ (2015) Increasing compliance with national quality measures for stroke through use of a standard order set. Am J Health Syst Pharm 72(11 Suppl 1):S6\u2013S10. \n                    https:\/\/doi.org\/10.2146\/ajhp150094","journal-title":"Am J Health Syst Pharm"},{"issue":"16","key":"1739_CR27","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","volume":"372","author":"MS Sabatine","year":"2015","unstructured":"Sabatine MS, Giugiano RP, Wiviott SD et al (2015) Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. N Engl J Med 372(16):1500\u20131509. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1500858","journal-title":"N Engl J Med"},{"key":"1739_CR28","unstructured":"Health Services Executive, Clinical Strategy and Programmes Division. National Clinical Programmes: Stroke. \n                    http:\/\/www.hse.ie\/eng\/about\/Who\/cspd\/ncps\/stroke\/\n                    \n                   Accessed 27 December 2017"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-018-1739-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-018-1739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-018-1739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T22:23:08Z","timestamp":1589840588000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-018-1739-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,24]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1007\/s11845-018-1739-8","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"type":"print","value":"0021-1265"},{"type":"electronic","value":"1863-4362"}],"subject":[],"published":{"date-parts":[[2018,1,24]]},"assertion":[{"value":"4 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from participating institutions and the Irish College of General Practitioners. Informed consent was obtained from patients or next-of-kin.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}